Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.
about
Postinfarct Left Ventricular Remodelling: A Prevailing Cause of Heart FailureCell Therapy in Ischemic Heart Disease: Interventions That Modulate Cardiac RegenerationRemote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute WorkshopRole of the MPTP in conditioning the heart - translatability and mechanismGLP-1 and cardioprotection: from bench to bedsideDifferential Effects of E2 on MAPK Activity in the Brain and Heart of Aged Female RatsProspects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor AgonistsIschaemic conditioning and targeting reperfusion injury: a 30 year voyage of discoveryMitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.Intermittent losartan administration triggers cardiac post-conditioning in isolated rat hearts: role of BK2 receptorsTargeting of adenosine receptors in ischemia-reperfusion injury.Nonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon.Concentration-dependent wrestling between detrimental and protective effects of H2O2 during myocardial ischemia/reperfusionPI3Kgamma protects from myocardial ischemia and reperfusion injury through a kinase-independent pathway.Is there a role for ischaemic conditioning in cardiac surgery?Adenosine A1 receptor activation increases myocardial protein S-nitrosothiols and elicits protection from ischemia-reperfusion injury in male and female heartsEffects of novel semiselective matrix metalloproteinase inhibitors on ex vivo cardiac structure-function.Cyclosporine A at reperfusion reduces infarct size in pigsHigh carbohydrate and high fat diets protect the heart against ischaemia/reperfusion injuryCardiac preconditioning with sphingosine-1-phosphate requires activation of signal transducer and activator of transcription-3.The novel adipocytokine visfatin exerts direct cardioprotective effectsEffects of (-)-epicatechin on myocardial infarct size and left ventricular remodeling after permanent coronary occlusionRegulation of intracellular signaling and function by caveolin.Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms.Human catestatin peptides differentially regulate infarct size in the ischemic-reperfused rat heartSustained ligand-activated preconditioning via δ-opioid receptorsHydrogen sulfide provides cardioprotection against myocardial/ischemia reperfusion injury in the diabetic state through the activation of the RISK pathwayProtection against myocardial ischemia-reperfusion injury at onset of type 2 diabetes in Zucker diabetic fatty rats is associated with altered glucose oxidation.GPER mediates cardiotropic effects in spontaneously hypertensive rat hearts.ZFP580, a novel zinc-finger transcription factor, is involved in cardioprotection of intermittent high-altitude hypoxia against myocardial ischemia-reperfusion injury.Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study.Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 PhosphorylationGenetic and pharmacologic inhibition of Tpl2 kinase is protective in a mouse model of ventilator-induced lung injury.Blockade of electron transport at the onset of reperfusion decreases cardiac injury in aged hearts by protecting the inner mitochondrial membrane.Clinical applications of remote ischaemic preconditioning in native and transplant acute kidney injuryDifferences in myocardial PTEN expression and Akt signalling in type 2 diabetic and nondiabetic patients undergoing coronary bypass surgeryThe Mitochondrial Permeability Transition Pore: Channel Formation by F-ATP Synthase, Integration in Signal Transduction, and Role in Pathophysiology.Cyclosporin variably and inconsistently reduces infarct size in experimental models of reperfused myocardial infarction: a systematic review and meta-analysis.Remote Liver Ischemic Preconditioning Protects against Sudden Cardiac Death via an ERK/GSK-3β-Dependent Mechanism.Topological control of nitric oxide secretion by tantalum oxide nanodot arrays.
P2860
Q26753845-B6147849-D508-4FC6-9560-ED953E9D9CFDQ26765916-B652C92F-5947-4789-A589-21FE9B2CF8CBQ26828968-C7B55556-8C79-44ED-B7D3-0960432AD026Q26830560-73F153CF-F8A4-4892-B307-2CE2E9F12594Q27024984-DB3F785F-03F7-4CFE-8B63-43B04E9A1FD3Q27332213-7B020517-40B4-45E8-8AA6-3526A9D712ADQ28066192-A6F26DE9-7297-46EE-83BB-0C81CB5785B5Q28072918-5E8B45C5-408B-4534-B925-F3BEEC322FD5Q28296128-B52A891F-5783-403D-9BD1-C3EB829D9F56Q28539671-A1CAB523-7220-40C2-83C8-77BE6BB363A0Q30429069-7DC7B259-641C-4641-BC73-E4AABB903CA8Q30583012-3320FED9-2B5C-435C-B346-06354402023BQ30669527-201C32DB-2D61-42E3-A4B4-FE605962DBD6Q33533748-52ABAA97-41D8-4993-A35F-68197C82348EQ33605260-2B176677-B1AA-42C5-8108-DDB07FE45E91Q33663800-38A21FDD-9E94-4880-991E-8AFD2BB515EDQ33715912-1F8E4684-2CA0-4C8C-8EDE-61B6FE6E252AQ33791098-49CD73CD-89EF-476E-AD9B-98EAFE744DE0Q33948647-321C2190-B1E6-4712-A02F-CEA9D6C13731Q33995071-B511FFA0-6D11-4419-94FF-6674387CA35FQ34001681-21AD4AEE-32F0-429A-B606-045C8EF06870Q34042151-7DA5F95F-D96A-4167-A3EA-3E42BF7724AAQ34072649-B8D814E6-6A8A-4050-BDA3-B92D68DFDA58Q34253155-54F69B24-83E1-457A-9993-93EBE32FA17CQ34388245-13F875CB-0F46-42CF-84CA-B8EA8B753145Q34458657-DDE4346A-6EE6-4899-B56C-F2CCFBAC91A1Q34728629-F1501A49-F7F8-41C0-80F0-088626D1D1D3Q34737959-3A22BE8E-C22E-407E-BD2C-77AF59DEBEDCQ34946257-A2837E73-C8C5-40C0-A2C9-385697B9F465Q35145267-03F605A5-D9A3-45ED-9666-DD2779185EBCQ35587397-C1055875-E160-4026-8A4B-A3E2BE61DF83Q35860938-3F69929C-325C-46F1-BAE2-32DEE5E38C80Q35883560-7B99E1B9-FD7A-4923-8A62-F71562AD14C8Q35944872-0BD7E0F8-28E5-4341-A2A6-6A089A89EDE3Q35995871-8DF3ED35-6AB2-4507-98E9-7DB3FA6AF4F3Q36043779-D5D185A4-76C2-4E43-9020-FCF3F10CC4A8Q36146320-A39E04D6-C949-41C8-A868-FC954BBB0A11Q36147255-4864AF31-CBC3-48F3-AC58-530E9D432EFBQ36170828-A4D55C36-CEA7-4A00-A90C-57EC9D234D4DQ36266825-2B80AAE5-2D67-42FF-818F-6891F4AF9B5D
P2860
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.
@en
type
label
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.
@en
prefLabel
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.
@en
P1476
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection
@en
P2888
P304
P356
10.1007/S10741-007-9026-1
P577
2007-12-01T00:00:00Z